Is there hope in improving 5-year overall survival?-review of 5-year overall survival data from KEYNOTE-001

被引:0
作者
Akingbemi, Wisdom [1 ]
Garon, Edward [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Hematol Oncol, Los Angeles, CA 90095 USA
关键词
D O I
10.21037/atm-2020-95
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 9 条
[1]   Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure? [J].
Bironzo, Paolo ;
Passiglia, Francesco ;
Novello, Silvia .
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
[2]   Are we facing a cure in lung cancer?-KEYNOTE-001 insights [J].
Cohen, Aharon Y. ;
Kian, Waleed ;
Roisman, Laila C. ;
Levitas, Dina ;
Peled, Nir ;
Dudnik, Yulia .
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
[3]   Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study [J].
Garon, Edward B. ;
Hellmann, Matthew D. ;
Rizvi, Naiyer A. ;
Carcereny, Enric ;
Leighl, Natasha B. ;
Ahn, Myung-Ju ;
Eder, Joseph Paul ;
Balmanoukian, Ani S. ;
Aggarwal, Charu ;
Horn, Leora ;
Patnaik, Amita ;
Gubens, Matthew ;
Ramalingam, Suresh S. ;
Felip, Enriqueta ;
Goldman, Jonathan W. ;
Scalzo, Cathie ;
Jensen, Erin ;
Kush, Debra A. ;
Hui, Rina .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (28) :2518-+
[4]   Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [J].
Garon, Edward B. ;
Rizvi, Naiyer A. ;
Hui, Rina ;
Leighl, Natasha ;
Balmanoukian, Ani S. ;
Eder, Joseph Paul ;
Patnaik, Amita ;
Aggarwal, Charu ;
Gubens, Matthew ;
Horn, Leora ;
Carcereny, Enric ;
Ahn, Myung-Ju ;
Felip, Enriqueta ;
Lee, Jong-Seok ;
Hellmann, Matthew D. ;
Hamid, Omid ;
Goldman, Jonathan W. ;
Soria, Jean-Charles ;
Dolled-Filhart, Marisa ;
Rutledge, Ruth Z. ;
Zhang, Jin ;
Lunceford, Jared K. ;
Rangwala, Reshma ;
Lubiniecki, Gregory M. ;
Roach, Charlotte ;
Emancipator, Kenneth ;
Gandhi, Leena .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) :2018-2028
[5]   Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer [J].
Hellmann, M. D. ;
Paz-Ares, L. ;
Bernabe Caro, R. ;
Zurawski, B. ;
Kim, S. -W. ;
Carcereny Costa, E. ;
Park, K. ;
Alexandru, A. ;
Lupinacci, L. ;
de la Mora Jimenez, E. ;
Sakai, H. ;
Albert, I. ;
Vergnenegre, A. ;
Peters, S. ;
Syrigos, K. ;
Barlesi, F. ;
Reck, M. ;
Borghaei, H. ;
Brahmer, J. R. ;
O'Byrne, K. J. ;
Geese, W. J. ;
Bhagavatheeswaran, P. ;
Rabindran, S. K. ;
Kasinathan, R. S. ;
Nathan, F. E. ;
Ramalingam, S. S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) :2020-2031
[6]   Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) [J].
Incorvaia, Lorena ;
Fanale, Daniele ;
Badalamenti, Giuseppe ;
Barraco, Nadia ;
Bono, Marco ;
Corsini, Lidia Rita ;
Galvano, Antonio ;
Gristina, Valerio ;
Listi, Angela ;
Vieni, Salvatore ;
Gori, Stefania ;
Bazan, Viviana ;
Russo, Antonio .
ADVANCES IN THERAPY, 2019, 36 (10) :2600-2617
[7]   STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma [J].
Skoulidis, Ferdinandos ;
Goldberg, Michael E. ;
Greenawalt, Danielle M. ;
Hellmann, Matthew D. ;
Awad, Mark M. ;
Gainor, Justin F. ;
Schrock, Alexa B. ;
Hartmaier, Ryan J. ;
Trabucco, Sally E. ;
Gay, Laurie ;
Ali, Siraj M. ;
Elvin, Julia A. ;
Singal, Gaurav ;
Ross, Jeffrey S. ;
Fabrizio, David ;
Szabo, Peter M. ;
Chang, Han ;
Sasson, Ariella ;
Srinivasan, Sujaya ;
Kirov, Stefan ;
Szustakowski, Joseph ;
Vitazka, Patrik ;
Edwards, Robin ;
Bufill, Jose A. ;
Sharma, Neelesh ;
Ou, Sai-Hong I. ;
Peled, Nir ;
Spigel, David R. ;
Rizvi, Hira ;
Aguilar, Elizabeth Jimenez ;
Carter, Brett W. ;
Erasmus, Jeremy ;
Halpenny, Darragh F. ;
Plodkowski, Andrew J. ;
Long, Niamh M. ;
Nishino, Mizuki ;
Denning, Warren L. ;
Galan-Cobo, Ana ;
Hamdi, Haifa ;
Hirz, Taghreed ;
Tong, Pan ;
Wang, Jing ;
Rodriguez-Canales, Jaime ;
Villalobos, Pamela A. ;
Parra, Edwin R. ;
Kalhor, Neda ;
Sholl, Lynette M. ;
Sauter, Jennifer L. ;
Jungbluth, Achim A. ;
Mino-Kenudson, Mari .
CANCER DISCOVERY, 2018, 8 (07) :822-835
[8]   Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab [J].
Topalian, Suzanne L. ;
Hodi, F. Stephen ;
Brahmer, Julie R. ;
Gettinger, Scott N. ;
Smith, David C. ;
McDermott, David F. ;
Powderly, John D. ;
Sosman, Jeffrey A. ;
Atkins, Michael B. ;
Leming, Philip D. ;
Spigel, David R. ;
Antonia, Scott J. ;
Drilon, Alexander ;
Wolchok, Jedd D. ;
Carvajal, Richard D. ;
McHenry, M. Brent ;
Hosein, Fareeda ;
Harbison, Christopher T. ;
Grosso, Joseph F. ;
Sznol, Mario .
JAMA ONCOLOGY, 2019, 5 (10) :1411-1420
[9]   Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma [J].
Zaretsky, Jesse M. ;
Garcia-Diaz, Angel ;
Shin, Daniel S. ;
Escuin-Ordinas, Helena ;
Hugo, Willy ;
Hu-Lieskovan, Siwen ;
Torrejon, Davis Y. ;
Abril-Rodriguez, Gabriel ;
Sandoval, Salemiz ;
Barthly, Lucas ;
Saco, Justin ;
Moreno, Blanca Homet ;
Mezzadra, Riccardo ;
Chmielowski, Bartosz ;
Ruchalski, Kathleen ;
Shintaku, I. Peter ;
Sanchez, Phillip J. ;
Puig-Saus, Cristina ;
Cherry, Grace ;
Seja, N. P. Elizabeth ;
Kong, Xiangju ;
Pang, Jia ;
Berent-Maoz, Beata ;
Comin-Anduix, Begona ;
Graeber, Thomas G. ;
Tumeh, Paul C. ;
Schumacher, Ton N. M. ;
Lo, Roger S. ;
Ribas, Antoni .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (09) :819-829